Z

Zai Lab Limited
D

ZLAB

33.780
USD
2.75
(8.86%)
Market Closed
Volume
57,619
EPS
-0
Div Yield
-
P/E
-12
Market Cap
3,679,897,062
OverviewSignalsIdeasNews
Related Instruments
    ADBE
    ADBE
    -10.26
    (-2.26%)
    444.30 USD
    CRWD
    CRWD
    -29.49
    (-6.76%)
    406.64 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    NVDA
    NVDA
    -5.850
    (-4.18%)
    134.260 USD
    O
    OKTA
    -2.450
    (-2.57%)
    92.740 USD
    PANW
    PANW
    -7.720
    (-3.88%)
    191.080 USD
    TEAM
    TEAM
    -12.38
    (-4.15%)
    286.04 USD
    V
    VEEV
    -2.960
    (-1.29%)
    225.900 USD
    More
News

Title: Zai Lab Limited

Sector: Healthcare
Industry: Biotechnology
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.